Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:06 UTC |
---|
HMDB ID | HMDB0000721 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Glycylproline |
---|
Description | Glycylproline is a dipeptide composed of glycine and proline, and is an end product of collagen metabolism that is further cleaved by prolidase (EC 3.4.13.9). The resulting proline molecules are recycled into collagen or other proteins. Prolidase deficiency is a rare autosomal recessive disease characterized by chronic ulcerative dermatitis, mental retardation, frequent infections, and massive urinary excretion of iminodipeptides. Patients with this disease have reportedly decreased prolidase enzyme activity against glycylproline (Gly-Pro). The enzyme's activity against other substrates is not as affected. Some patients with prolidase deficiency have a marked urinary excretion of glycylproline. Patients with pressure sores contain significantly more urinary glycylproline than the control (PMID: 16009141 , 7629169 , 1536787 , 10582130 ). |
---|
Structure | InChI=1S/C7H12N2O3/c8-4-6(10)9-3-1-2-5(9)7(11)12/h5H,1-4,8H2,(H,11,12)/t5-/m0/s1 |
---|
Synonyms | Value | Source |
---|
1-(Aminoacetyl)proline | ChEBI | 1-Glycylproline | ChEBI | Gly-L-pro | ChEBI | GP | ChEBI | N-Glycyl-L-proline | ChEBI | N-Glycylproline | ChEBI | Glycyl-L-proline | HMDB | (S)-1-(2-Aminoacetyl)pyrrolidine-2-carboxylic acid | HMDB | 1-Glycyl-L-proline | HMDB | g-p Dipeptide | HMDB | GP Dipeptide | HMDB | Gly-pro | HMDB | Glycine proline dipeptide | HMDB | Glycine-proline dipeptide | HMDB | Glycyl-proline | HMDB | NSC 97929 | HMDB | Glycylproline | ChEBI |
|
---|
Chemical Formula | C7H12N2O3 |
---|
Average Molecular Weight | 172.1818 |
---|
Monoisotopic Molecular Weight | 172.08479226 |
---|
IUPAC Name | (2S)-1-(2-aminoacetyl)pyrrolidine-2-carboxylic acid |
---|
Traditional Name | glycylproline |
---|
CAS Registry Number | 704-15-4 |
---|
SMILES | NCC(=O)N1CCC[C@H]1C(O)=O |
---|
InChI Identifier | InChI=1S/C7H12N2O3/c8-4-6(10)9-3-1-2-5(9)7(11)12/h5H,1-4,8H2,(H,11,12)/t5-/m0/s1 |
---|
InChI Key | KZNQNBZMBZJQJO-YFKPBYRVSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- Proline or derivatives
- N-acyl-alpha-amino acid
- N-acyl-l-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- N-acylpyrrolidine
- Pyrrolidine carboxylic acid or derivatives
- Pyrrolidine carboxylic acid
- Tertiary carboxylic acid amide
- Pyrrolidine
- Amino acid or derivatives
- Carboxamide group
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Primary aliphatic amine
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Amine
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 155 - 158 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Glycylproline,1TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN | 1711.6 | Semi standard non polar | 33892256 | Glycylproline,1TMS,isomer #2 | C[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O | 1790.5 | Semi standard non polar | 33892256 | Glycylproline,2TMS,isomer #1 | C[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 1808.0 | Semi standard non polar | 33892256 | Glycylproline,2TMS,isomer #1 | C[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 1831.4 | Standard non polar | 33892256 | Glycylproline,2TMS,isomer #1 | C[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C | 2342.3 | Standard polar | 33892256 | Glycylproline,2TMS,isomer #2 | C[Si](C)(C)N(CC(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 1922.0 | Semi standard non polar | 33892256 | Glycylproline,2TMS,isomer #2 | C[Si](C)(C)N(CC(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 1935.1 | Standard non polar | 33892256 | Glycylproline,2TMS,isomer #2 | C[Si](C)(C)N(CC(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C | 2542.5 | Standard polar | 33892256 | Glycylproline,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN([Si](C)(C)C)[Si](C)(C)C | 1974.7 | Semi standard non polar | 33892256 | Glycylproline,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN([Si](C)(C)C)[Si](C)(C)C | 1970.0 | Standard non polar | 33892256 | Glycylproline,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN([Si](C)(C)C)[Si](C)(C)C | 2166.4 | Standard polar | 33892256 | Glycylproline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN | 1943.3 | Semi standard non polar | 33892256 | Glycylproline,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O | 2014.2 | Semi standard non polar | 33892256 | Glycylproline,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2252.2 | Semi standard non polar | 33892256 | Glycylproline,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2274.2 | Standard non polar | 33892256 | Glycylproline,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCC(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C | 2474.4 | Standard polar | 33892256 | Glycylproline,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2336.3 | Semi standard non polar | 33892256 | Glycylproline,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2352.5 | Standard non polar | 33892256 | Glycylproline,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C | 2597.1 | Standard polar | 33892256 | Glycylproline,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2571.0 | Semi standard non polar | 33892256 | Glycylproline,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2586.7 | Standard non polar | 33892256 | Glycylproline,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2469.0 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Glycylproline GC-MS (3 TMS) | splash10-00di-2901000000-1b9ae10ce7fa6c3ddfba | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Glycylproline GC-EI-TOF (Non-derivatized) | splash10-00di-1901000000-f37ccc8ccf214e97d6b6 | 2019-03-08 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Glycylproline GC-EI-TOF (Non-derivatized) | splash10-00di-1901000000-f37ccc8ccf214e97d6b6 | 2019-03-08 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Glycylproline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Glycylproline GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Glycylproline GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Glycylproline GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Glycylproline GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-00di-1900000000-9da065ddc26b31b36592 | 2019-03-08 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-01b9-5900000000-583b4cb589c2ec738f36 | 2019-03-08 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-00di-9000000000-7bdaea720328b0c3851e | 2019-03-08 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 30V, Positive-QTOF | splash10-00di-9000000000-524b721e73f3f887c681 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 40V, Positive-QTOF | splash10-00di-9000000000-2940e6237c21dbb5beee | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 10V, Positive-QTOF | splash10-00xr-7900000000-2c485a901dc7d65e0c7a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 0V, Positive-QTOF | splash10-00di-6900000000-0809cb7a542853d1a964 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 30V, Positive-QTOF | splash10-00fv-9000000000-0f3f6db9502dba42c40a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 0V, Positive-QTOF | splash10-00di-0900000000-691af9a68cb0bc804261 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 20V, Positive-QTOF | splash10-00di-9300000000-f89829e245592af7832e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 10V, Positive-QTOF | splash10-01b9-2900000000-07189ee8865b832b5d35 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 10V, Positive-QTOF | splash10-01b9-2900000000-5da22ef9598476d82c7f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glycylproline 30V, Positive-QTOF | splash10-00di-9100000000-e5f29a91a023b15855ec | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 10V, Positive-QTOF | splash10-05fr-1900000000-6987035260ca993cd43e | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 20V, Positive-QTOF | splash10-0ac0-9600000000-c74cee61fd2ec534af77 | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 40V, Positive-QTOF | splash10-014l-9000000000-48d0c933c8b6f78e839f | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 10V, Negative-QTOF | splash10-00fr-0900000000-55b1206a1419a41e86ff | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 20V, Negative-QTOF | splash10-00b9-3900000000-6739642d8410a9a177ed | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 40V, Negative-QTOF | splash10-00di-9200000000-16170c56a5433313b0aa | 2019-02-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 10V, Negative-QTOF | splash10-03k9-0900000000-c96e09599210c8ad1286 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 20V, Negative-QTOF | splash10-03di-5900000000-ee573e16cf640a002b33 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 40V, Negative-QTOF | splash10-0006-9200000000-04634bf9835152674496 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 10V, Positive-QTOF | splash10-01b9-4900000000-47d2ea68a762ed22c884 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 20V, Positive-QTOF | splash10-00xs-9400000000-87dbef1e712c254ed5aa | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glycylproline 40V, Positive-QTOF | splash10-00di-9000000000-ce80042f9a9ea592870e | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2019-03-08 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Not Specified | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Children (1 - 2 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Children (2 - 4 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Children (4 - 13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Adolescent (13 - 21 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0 - 16.17 umol/mmol creatinine | Adult (>21 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.4-2.8 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 1.1-2.0 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.4 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 61.403 +/- 24.479 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.23 +/- 0.04 uM | Elderly (>65 years old) | Both | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.086 +/- 0.016 uM | Elderly (>65 years old) | Both | Alzheimer's disease | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 590.8 +/- 81.14 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Prolidase deficiency | | details | Urine | Detected and Quantified | 0.0087 +/- 0.0016 umol/mmol creatinine | Elderly (>65 years old) | Both | Alzheimer's disease | | details | Urine | Detected and Quantified | 46.339 +/- 42.779 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Prolidase deficiency |
---|
- Barshop BA: Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion. 2004 Sep;4(5-6):521-7. Epub 2004 Sep 30. [PubMed:16120410 ]
- Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38. [PubMed:2026685 ]
| Alzheimer's disease |
---|
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10. [PubMed:17031479 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022202 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 2282246 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | CPD-10814 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 3013625 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 70744 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | GLYPRO |
---|
MarkerDB ID | MDB00000236 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Maruyama, Susumu; Ichimura, Toshiaki; Otsuka, Tatsuo; Yamashita, Eiichi. Long-lasting antihypertensive agents and glycylproline manufactured from collagen and/or gelatin. Jpn. Kokai Tokkyo Koho (2005), 10 pp. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38. [PubMed:2026685 ]
- Ohdoi C, Nyhan WL, Kuhara T: Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792(1):123-30. [PubMed:12829005 ]
- Barshop BA: Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion. 2004 Sep;4(5-6):521-7. Epub 2004 Sep 30. [PubMed:16120410 ]
- Krepela E, Kasafirek E, Vicar J, Kraml J: An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates. Physiol Bohemoslov. 1983;32(4):334-45. [PubMed:6353449 ]
- Liu G, Nakayama K, Sagara Y, Awata S, Yamashita K, Manabe M, Kodama H: Characterization of prolidase activity in erythrocytes from a patient with prolidase deficiency: comparison with prolidase I and II purified from normal human erythrocytes. Clin Biochem. 2005 Jul;38(7):625-31. [PubMed:16009141 ]
- Mock WL, Liu Y: Hydrolysis of picolinylprolines by prolidase. A general mechanism for the dual-metal ion containing aminopeptidases. J Biol Chem. 1995 Aug 4;270(31):18437-46. [PubMed:7629169 ]
- Berardesca E, Fideli D, Bellosta M, Dyne KM, Zanaboni G, Cetta G: Blood transfusions in the therapy of a case of prolidase deficiency. Br J Dermatol. 1992 Feb;126(2):193-5. [PubMed:1536787 ]
- Le J, Perier C, Peyroche S, Rascle F, Blanchon MA, Gonthier R, Frey J, Chamson A: Urine glycyl-L-proline increase and skin trophicity. Amino Acids. 1999;17(3):315-22. [PubMed:10582130 ]
|
---|